These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36755905)

  • 1. Cost-effectiveness analysis of induction of labour at 41 weeks and expectant management until 42 weeks in low risk women (INDEX trial).
    Bruinsma A; Keulen JK; van Eekelen R; van Wely M; Kortekaas JC; van Dillen J; van de Post JA; Mol BW; de Miranda E
    Eur J Obstet Gynecol Reprod Biol X; 2023 Mar; 17():100178. PubMed ID: 36755905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective induction of labour and expectant management in late-term pregnancy: A prospective cohort study alongside the INDEX randomised controlled trial.
    Bruinsma A; Keulen JK; Kortekaas JC; van Dillen J; Duijnhoven RG; Bossuyt PM; van Kaam AH; van der Post JA; Mol BW; de Miranda E
    Eur J Obstet Gynecol Reprod Biol X; 2022 Dec; 16():100165. PubMed ID: 36262791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
    Keulen JK; Bruinsma A; Kortekaas JC; van Dillen J; Bossuyt PM; Oudijk MA; Duijnhoven RG; van Kaam AH; Vandenbussche FP; van der Post JA; Mol BW; de Miranda E
    BMJ; 2019 Feb; 364():l344. PubMed ID: 30786997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of labour at 41 weeks of gestation versus expectant management and induction of labour at 42 weeks of gestation: A cost-effectiveness analysis.
    Alkmark M; Wennerholm UB; Saltvedt S; Bergh C; Carlsson Y; Elden H; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Hagberg H; Svensson M
    BJOG; 2022 Dec; 129(13):2157-2165. PubMed ID: 34534404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials.
    Alkmark M; Keulen JKJ; Kortekaas JC; Bergh C; van Dillen J; Duijnhoven RG; Hagberg H; Mol BW; Molin M; van der Post JAM; Saltvedt S; Wikström AK; Wennerholm UB; de Miranda E
    PLoS Med; 2020 Dec; 17(12):e1003436. PubMed ID: 33290410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
    Wennerholm UB; Saltvedt S; Wessberg A; Alkmark M; Bergh C; Wendel SB; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Wennergren G; Wikström AK; Elden H; Stephansson O; Hagberg H
    BMJ; 2019 Nov; 367():l6131. PubMed ID: 31748223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis.
    Hersh AR; Skeith AE; Sargent JA; Caughey AB
    Am J Obstet Gynecol; 2019 Jun; 220(6):590.e1-590.e10. PubMed ID: 30768934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.
    Biesty LM; Egan AM; Dunne F; Dempsey E; Meskell P; Smith V; Ni Bhuinneain GM; Devane D
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012910. PubMed ID: 29303230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
    Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
    Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and neonatal outcomes of elective induction of labor.
    Caughey AB; Sundaram V; Kaimal AJ; Cheng YW; Gienger A; Little SE; Lee JF; Wong L; Shaffer BL; Tran SH; Padula A; McDonald KM; Long EF; Owens DK; Bravata DM
    Evid Rep Technol Assess (Full Rep); 2009 Mar; (176):1-257. PubMed ID: 19408970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies.
    Grobman WA; Caughey AB
    Am J Obstet Gynecol; 2019 Oct; 221(4):304-310. PubMed ID: 30817905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.
    Bond DM; Gordon A; Hyett J; de Vries B; Carberry AE; Morris J
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009433. PubMed ID: 26599471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing induction of labour at 41 or 42 weeks? A closer look at time frames of comparison: A review.
    Keulen JKJ; Bruinsma A; Kortekaas JC; van Dillen J; van der Post JAM; de Miranda E
    Midwifery; 2018 Nov; 66():111-118. PubMed ID: 30170263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial).
    Vijgen SM; Boers KE; Opmeer BC; Bijlenga D; Bekedam DJ; Bloemenkamp KW; de Boer K; Bremer HA; le Cessie S; Delemarre FM; Duvekot JJ; Hasaart TH; Kwee A; van Lith JM; van Meir CA; van Pampus MG; van der Post JA; Rijken M; Roumen FJ; van der Salm PC; Spaanderman ME; Willekes C; Wijnen EJ; Mol BW; Scherjon SA
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):358-63. PubMed ID: 23910171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of elective induction of labour compared with expectant management: population based study.
    Stock SJ; Ferguson E; Duffy A; Ford I; Chalmers J; Norman JE
    BMJ; 2012 May; 344():e2838. PubMed ID: 22577197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective induction of labor versus expectant management at 39 weeks among low-risk nulliparous pregnant women: A randomized controlled trial in India (ELITE-39 trial).
    Lalithadevi P; Rengaraj S; Dasari P; Adhisivam B
    Int J Gynaecol Obstet; 2024 Oct; 167(1):427-433. PubMed ID: 38708604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnant women's willingness to participate in a randomized trial comparing induction of labor at 39 weeks versus expectant management: A survey in the Netherlands.
    Croll DMR; Meuleman T; de Heus R; de Boer MA; Verhoeven CJM; Bloemenkamp KWM; van Dillen J
    Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():7-11. PubMed ID: 35436644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women.
    Einerson BD; Nelson RE; Sandoval G; Esplin MS; Branch DW; Metz TD; Silver RM; Grobman WA; Reddy UM; Varner M;
    Obstet Gynecol; 2020 Jul; 136(1):19-25. PubMed ID: 32541288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of induction of labour at term with a Foley catheter compared to vaginal prostaglandin E₂ gel (PROBAAT trial).
    van Baaren GJ; Jozwiak M; Opmeer BC; Oude Rengerink K; Benthem M; Dijksterhuis MG; van Huizen ME; van der Salm PC; Schuitemaker NW; Papatsonis DN; Perquin DA; Porath M; van der Post JA; Rijnders RJ; Scheepers HC; Spaanderman M; van Pampus MG; de Leeuw JW; Mol BW; Bloemenkamp KW
    BJOG; 2013 Jul; 120(8):987-95. PubMed ID: 23530729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
    Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.